Barclays has initiated coverage on LifeStance Health Group Inc (LFST) with an Overweight rating, marking the firm's first assessment of the company. This decision reflects Barclays' analysis of LifeStance's business dynamics, industry trends, and growth prospects.
Headquartered in Scottsdale, Arizona, LifeStance Health Group provides outpatient mental health services across the United States. The company employs approximately 7,708 full-time staff and operates over 550 centers in 33 states. LifeStance focuses on delivering both virtual and in-person mental healthcare for children, adolescents, and adults facing various mental health challenges, including anxiety, depression, and post-traumatic stress disorder.
As of December 2, 2025, LifeStance's market capitalization stands at $2.5 billion, with a trailing twelve-month earnings per share (EPS) of -0.02. The company is scheduled to report its next earnings on February 26, 2026, with revenue expectations of $385.6 million.
Analyst ratings serve as professional opinions based on thorough research and financial modeling. While they can provide valuable insights, these assessments are inherently subject to change as new information emerges. Investors should consider a range of factors, including company fundamentals and competitive positioning, before making decisions. The current analyst consensus for LifeStance is a Buy, with 5 Strong Buy, 8 Buy, and 2 Hold ratings out of a total of 15 analysts surveyed as of December 1, 2025.